Tarsus Pharmaceuticals, Inc. TARS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s quick ratio?
- Tarsus Pharmaceuticals, Inc. (TARS) reported quick ratio of 3.7× in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s quick ratio changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s quick ratio decreased by 32.8% year-over-year, from 5.5× to 3.7×.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s quick ratio has grown at a -34.4% compound annual growth rate (CAGR), from 31.7× to 3.8×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.